D6808 is a Highly Selective c‑Met Inhibitor used for NSCLC and Gastric Cancer Research
c-Met is a unique subfamily member of receptor tyrosine kinase (RTK) behaving as the receptor of hepatocyte growth factor (HGF)/scatter factor (SF). The HGF/c-Met signaling pathway plays important roles in…